Showing results (341-350 of 7,735) with videos related to
Sort By:
Pageof 774
Pharmacological Research|September 18, 2022
Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transitionHuihai Yang, Grace Gar-Lee Yue, Ping-Chung Leung, et al.Pharmacological Research|December 17, 2021
Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategiesZheng-Zheng Zhang, Tian Wang, Xiao-Feng Wang, et al.Pharmacological Research|December 10, 2021
Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesisJoana B Loureiro, Rita Ribeiro, Nair Nazareth, et al.Pharmacological Research|January 10, 2022
Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination modificationQiang Guo, Yi-Chi Zhang, Wei Wang, et al.Pharmacological Research|December 13, 2021
Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injurySuravi Majumder, Sathnur Pushpakumar, Subir K Juin, et al.Pharmacological Research|December 16, 2021
Pathway network of pyroptosis and its potential inhibitors in acute kidney injuryNing Li, Yuru Wang, Xinyue Wang, et al.Pharmacological Research|November 24, 2021
Effects and mechanisms of dietary bioactive compounds on breast cancer preventionKumar Ganesan, Bing Du, Jianping ChenPharmacological Research|November 26, 2021
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironmentLucia Lisi, Pedro Miguel Lacal, Maria Martire, et al.Pharmacological Research|January 1, 2022
Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenibHua-Li Wang, Xue Ma, Xin-Yuan Guan, et al.Pharmacological Research|November 20, 2021
Salvianolic acid A relieves cognitive disorder after chronic cerebral ischemia: Involvement of Drd2/Cryab/NF-κB pathwayYujiao Yang, Junke Song, NanNan Liu, et al.Pageof 774